New treatment option for Amputation of Upper Limb
Official title Using Sensorimotor Reorganization Following Upper Limb Amputation to Improve Prosthetic Control
ClinicalTrials.gov ID: NCT07666204
What this study is testing
- What it's testing
- Amputation of an upper limb results in a disruption of the sensorimotor loop and a reorganization of the nervous system, leading to the emergence of a phantom limb and the adaptation of compensatory motor strategies. This project aims to leverage these phenomena (induced sensations, phantom mobility, and compensations) to improve control, sensory feedback, and the appropriation of prostheses, in order to reduce cognitive load and musculoskeletal disorders.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- people aged 18 or more
- amputation or agenesis of one uper limb, above the wrist or higher
- understanding of the French language and the ability to express onself in that language (for semi-structured interviews)
- affiliation to a social security programm
You likely can't join if
- history of progressive psychiatric or neurological disorders or disorders with residual effects
- pregnant or breastfeeding woman
- minor
- an adult under legal guardianship
- pain influencing movement (trunk, residual limb, phantom limb, contralateral limb)
The study team makes the final eligibility decision.
Where it's taking place
- Nancy, France
- Rennes, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nancy, France; Rennes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.